Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 13, 2017

Total Value ($000): $278,919 (100.0% shares, 0.0% debt)

Holdings (16)

UTHR UNITED THERAPEUTICS CORP 13.9%
Value ($000) $38,856 Shares 270,909 Est. Cost $136.10 Unrealized -6.2%
ENTA ENANTA PHARMACEUTICALS INC 12.7%
Value ($000) $35,367 Shares 1,055,719 Est. Cost $35.89 Unrealized -20.1%
GILD GILEAD SCIENCES INC 10.8%
Value ($000) $30,076 Shares 420,000 Est. Cost $53.19 Unrealized 0.0%
SUCAMPO PHARMACEUTICALS-CL A 9.1%
Value ($000) $25,254 Shares 1,863,755 Est. Cost $12.34 Unrealized
OM2 ORTHOFIX INTERNATIONAL NV 8.4%
Value ($000) $23,355 Shares 645,530 Est. Cost $32.01 Unrealized
HALYARD HEALTH INC 7.5%
Value ($000) $20,886 Shares 564,792 Est. Cost $40.74 Unrealized
AMGN AMGEN INC 6.7%
Value ($000) $18,592 Shares 127,157 Est. Cost $114.37 Unrealized 0.0%
INDIVIOR PLC 6.1%
Value ($000) $16,973 Shares 4,650,416 Est. Cost $3.34 Unrealized
MRK MERCK & CO. INC. 5.3%
Value ($000) $14,887 Shares 252,874 Est. Cost $39.26 Unrealized +12.3%
CNMD CONMED CORP 5.2%
Value ($000) $14,518 Shares 328,677 Est. Cost $37.99 Unrealized +1.9%
INVACARE CORP 5.2%
Value ($000) $14,389 Shares 1,102,586 Est. Cost $14.01 Unrealized
RTI SURGICAL INC 4.9%
Value ($000) $13,705 Shares 4,216,948 Est. Cost $4.41 Unrealized
DERMA SCIENCES INC 1.7%
Value ($000) $4,633 Shares 891,026 Est. Cost $4.57 Unrealized
AVIRAGEN THERAPEUTICS INC 1.2%
Value ($000) $3,367 Shares 2,737,602 Est. Cost $1.23 Unrealized
DIGIRAD CORP 0.9%
Value ($000) $2,432 Shares 486,400 Est. Cost $4.41 Unrealized
JUNIPER PHARMACEUTICALS INC 0.6%
Value ($000) $1,629 Shares 290,853 Est. Cost $9.19 Unrealized